Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by mri running title


Download 1.2 Mb.
Pdf ko'rish
bet2/7
Sana23.12.2017
Hajmi1.2 Mb.
#22870
1   2   3   4   5   6   7

Materials & Methods 

Contrast agents 

Platelet-specific contrast agent (LIBS-MPIO) 

The monoclonal “anti-LIBS”-antibody binds to ligand-induced binding sites (LIBS) on the 

GPIIb/IIIa-receptor only in its active conformation, and demonstrates strong binding to ADP-

activated platelets in the presence of fibrinogen 

19

. Cloning, generation and production of the “anti-



LIBS” single-chain antibody has previously been described in detail 

20

. To obtain a non-functional 



antibody for control purposes, exchange of the arginine in the RXD motif of the heavy chain 

CDR3 region of a single-chain antibody was performed. Generation and purification of the 

antibody was performed as described elsewhere 

15, 19, 21

. For construction of the contrast agent, 

schemia/reperfusion injury as well as the clinical relevance of the respective the

e

r

r



rape

p

p



u

ut

ut



ic

ic

ic r



r

r

ec



ec

ec

ep



ep

to

nhibition was confirmed in dual contrast MRI and histology in P2Y



12

 knockout mice undergoing

e

e

mp



mp

mpor


or

or

ar



ar

y



y LA

LA

LA



D

li



li

li

g



ga

gation.   



Ma

Ma

Mate

te

teri

ri

ri

al

al

s

s

s

&

&

&

Me

Me

eth

h

hod

od

d

s



Contrast age

ge

ge

nt

nt

nt



 by guest on December 22, 2017

http://circ.ahajournals.org/

Downloaded from 



DOI: 10.1161/CIRCULATIONAHA.113.008157 

cobalt-functionalised auto-fluorescent MPIOs with a diameter of 1 m were conjugated to the 



histidine-tag of the anti-LIBS/control single-chain antibody as described in the protocol of the 

manufacturer (Dynal Biotech, Oslo, Norway) and previously published studies 

22-24

. Throughout 



the manuscript, MPIOs conjugated to the anti-LIBS-antibody will be referred to as “LIBS-MPIO”, 

MPIOs conjugated to control antibody are named “control-MPIO”. Injection of the LIBS-MPIO 

and control-MPIO contrast agent (each with 4x10

8

 particles in 50μl saline) was via an 80 cm long 



tube and the tail vein catheter with the animal positioned in the MR scanner. Flushing the tube with 

100μl saline assured full injection. 



In vitro static and flow chamber adhesion assay 

Static assays were performed using small Petri dishes coated with washed platelets. Platelets were 

activated with 20μM ADP and incubated with MPIOs. In vitro flow chamber adhesion assays were 

performed using collagen coated glass capillaries 

25

. Microthrombi were formed by perfusion of 



whole blood into the capillary using a syringe pump (PhD 2000, Harvard Apparatus, USA). 

MPIOs were perfused through the capillary for 5 min. Both experiments were observed with IX81 

Olympus microscope (Olympus, Tokyo, Japan), and Cell^P 1692 (ANALYsis Image Processing) 

software, using DIC with a 20x objective. Binding was quantified using Image Pro Plus software.  



Gadolinium application 

Multihance™ (gadoben acid dimeglumin, Bracco Suisse) was used as paramagnetic Gadolinium 

based contrast agent for the late enhancement examination. A concentration of 0.4ml per kg body 

weight was diluted in 50μl of saline, and was administered via the tail vein catheter as described 

above.  

Animals

Eight to ten week old C57BL/6N mice (WT) were obtained from Charles River, Germany. P2Y

12

 

Static assays were performed using small Petri dishes coated with washed platelet



t

s

s



s. P

P

P



la

late


te

te

le



le

le

ts



ts

ts

w



w

w

er



er

e

activated with 20μM ADP and incubated with MPIOs. In vitro flow chamber adhesion assays were



pe

e

rf



rf

f

or



or

orm


me

me

d



d

us



u

u

i



i

ing 


g

co

co



coll

l

agen coated glass capillaries



s

s

 



25

25

25



.

 

Microthrombi



i

w

w



er

r



e

e

fo



fo

formed by perfusion of 

w

who


ol

ole blood in

n

to

to



o

 t

h



he

he c


c

ap

ap



p

il

il



il

la

la



la

ry

ry



y u

u

usi



si

ng

ng



ng

a

a s



s

s

yr



y

ring


e

e

p



p

pum


m

m

p



(PhD


hD

hD

2



2

00

00



000,

0

H



H

H

a



a

arv


v

ar

ar



d

Ap



Ap

Appa


pa

pa

ra



ratu

tu

s,



s

s

U



U

USA


SA

SA

).



)

). 


MP

MP

PIO



IO

IOs


s

s

we



were

re

re



p

per


er

f

fu



fu

se

se



s



th

th

h



ro

roug


ug

h



h

th

th



the

e

e



ca

ca

ca



pi

pi

ll



ll

l

ar



ar

ary


f



f

fo



r

r 5


5

5

m



mi

mi

n



n.

n

B



B

Bot


ot

oth


ex



ex

xpe


pe

p

r



ri

rime


me

ment


nt

n

s



s

s

w



we

were


re

e o


o

obs


bs

b

er



er

erv


ve

ved 


d

wi

wi



ith

th

I



I

I

X



X8

81

Olympus micr



cr

r

os



os

os

co



co

o

pe



pe

pe

(



(

(

Ol



O

O

ym



ym

m

pu



pu

pu

s,



s,

,

T



T

T

ok



ok

k

yo



yo

o



Ja

Ja



Ja

pa

pa



pa

n)

n)



n)

,



an

an

an



d

d



Ce

C

C



ll

ll

l



^P

^P

P



1

1

1



69

69

9



2



(A

(A

A



NA

NA

NA



LY

LY

LY



si

si

si



s

s

Im



Im

Im

ag



ag

ag

e



e

Pr



P

P

ocessing



 by guest on December 22, 2017

http://circ.ahajournals.org/

Downloaded from 



DOI: 10.1161/CIRCULATIONAHA.113.008157 

receptor-deficient (P2Y



12

-/-


) mice were kindly provided by J.-M. Boeynaems and B. Robaye 

(IRIBHM and Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium) 

26, 27

. P2Y


12

-/-


 

mice were also on a C57BL/6N background and all mice were housed in the local animal facility 

prior to the experiments. All experiments were conducted strictly according to the German 

animal protection law and in accordance with good animal practice as defined by FELASA 

(www.felasa.eu) and the national animal welfare body GV-SOLAS (www. gv-solas.de). The 

examinations undertaken in this study were approved by the Federal Authorities in Freiburg/IRB 

through the animal experiment permission 35/9185.81/G-09/47.  

Surgical procedures 

Mice were anesthetized with Ketamine (125 mg/kg, Pfizer Pharmacia GmbH, Berlin, Germany), 

Xylazine (6 mg/kg, Bayer Vital GmbH, Leverkusen, Germany) and 2% isoflurane (Abbott, 

Wiesbaden, Germany), and maintained at 37°C. After oro-tracheal intubation, mice were 

ventilated with a maximal end-inspiratory pressure of 10 cm H

2

O, at a respiratory rate of 



110/min, and an I/E ratio of 1/1.5 with a small animal respirator (TSE Systems, Bad Homburg, 

Germany). Left lateral thoracotomy in the third intercostal space was performed after right lateral 

positioning of the animal. The medial LAD was identified after pericardiotomy and ligated with 

an 8-0 prolene suture. Complete ligation was confirmed by paling of the anterior wall of the left 

ventricle and ST-elevation in 3-lead electrocardiography, and removed after 50 minutes to allow 

reperfusion. Pneumothorax was evacuated, and chest and skin were closed with a 6-0 prolene 

suture. Analgesia was provided with buprenorphine (0.1mg/kg s.c.) and mice were henceforth 

kept in individual clean cages. Throughout the procedure, oxygen saturation, respiratory rate, and 

heart rate were continually monitored with a MouseOX system (Starr Life Sciences, Oakmont, 

PA, USA) and maintained within the normal ranges. 

Mice were anesthetized with Ketamine (125 mg/kg, Pfizer Pharmacia GmbH, Be

Be

e



rl

rlin


in

n



Ge

Ge

Ge



rm

rm

rm



an

an

a



y)

y), 


Xylazine (6 mg/kg, Bayer Vital GmbH, Leverkusen, Germany) and 2% isoflurane (Abbott, 

Wi

Wi



es

es

es



ba

ba

bade



de

de

n,



n,

n, G


G

G

er



r

ma

ma



ma

ny

n



), and maintained at 37°C.

A

A



A

f

ft



fter oro-trachea

a

a



l

intu



tu

uba


ba

bation, mice were 

v

ven


nt

ntil


i

ated wit


t

h



a

a



m

ma

ma



xi

xi

xi



ma

ma

ma



l

l



en

en

end-



d-

d-

in



in

sp

sp



sp

ir

ir



i

a

at



t

o

or



ry p

pr

r



e

e

ssur



r

re

 of 



10

10

0 c



c

m

m



H

H



2

2

O



O,

O,

a



a

t



re



e

esp


p

ir

ir



ir

a

at



ator

or



y

y ra


ra

a

te



te

 of 


11



1

0/

0/



0

mi

mi



min,

n,

,



a

a

nd



nd

nd

a



a



I/

I/



E

ra



ra

a

ti



i

o

o



o

of

of



1

1

1



/1

/1

1 5



5

.5

w



w

w

it



ith

h

h



a

a sm



sm

sm

al



al

l

l



an

an



an

m

im



im

al

al



res

es

espi



pi

pira


ra

ato


to

to



r

(T

(T



TSE

SE

S



 S

y

ys



yste

te

ems



ms

ms,


,

,

Ba



Ba

Bad


d

d H


H

Ho

m



mb

mb

u



u

urg,


g,

g, 


Germany). Le

Le

e



ft

ft

ft



l

l

at



at

at

er



er

er

al



al

l

t



t

t

ho



ho

ra

ra



ra

co

co



c

to

to



o

my

my



my

i

i



n th

th

th



e

e

e



th

th

th



ir

ir

ir



d



in

in

n



te

te

t



rc

rc

r



os

s

s



ta

ta

ta



l

l



sp

sp

sp



ac

ac

ac



e



wa

wa

wa



s

s

pe



pe

pe

rf



rf

rf

or



or

or

me



me

e



d

af



af

af

te



te

te

r



r

right latera



a

a

 by guest on December 22, 2017



http://circ.ahajournals.org/

Downloaded from 



DOI: 10.1161/CIRCULATIONAHA.113.008157 



MRI protocols 

All magnetic resonance experiments were performed on a dedicated small animal MRI system 

(BioSpec70/20, Bruker Germany), run with AVANCE III electronics, Paravision 5.1 software, 

and employing a two channel cryogenically cooled mouse head surface coil.  

The animals were placed head first in supine position onto the cryo-coil animal bed supported by 

a cotton pad underneath the spine, in order to assure the mouse chest to fully fill the sensitive 

coil volume.  

For animal monitoring and sequence triggering, neonatal ECG electrodes were attached 

to the left front and the right hind paw of the mice. In addition, a breathing sensor pad was 

placed beneath the animal and animal temperature was maintained by warm-water supported 

heating of the animal cradle. During MRI, anesthesia was maintained via slowly introducing 

isoflurane up to a maximum of 2 Vol % in oxygen, stabilizing the animals at a breathing rate of 

approximately 70 breaths per minute. 

The MRI protocols consisted of three parts. First, a retrospectively gated multi slice 

Intragate-Flash pilot scan was performed in order to verify the animal position and to place the 

reference slice for transmitter gain adjustments of the cryo-coil. Planning of the final cardiac 

pseudo short axis slice position was performed using an ECG and respiration triggered standard 

FLASH sequence (TE/TR: 2.8/35 ms) acquiring three parallel slices. On an axial image, three 

sagittal slices through the left ventricle were tilted towards the coronary plane until parallel to the 

septum. Perpendicular on these images, three further slices were planned parallel to the 

imaginary line connecting the mid of the basis and the apex of the left ventricle. Finally, on these 

pseudo four chamber view images, the three left ventricular pseudo short axis slices were 

planned. For these, a respiration- and ECG-triggered FLASH sequence tailored to gain T

2

* and 


placed beneath the animal and animal temperature was maintained by warm-wat

at

e



e

er

s



s

s

up



up

p

po



po

po

rt



rt

rt

ed



ed

ed 


heating of the animal cradle. During MRI, anesthesia was maintained via slowly introducing 

s

s



of

of

f



lu

lu

lura



ra

ra

ne



ne

e

u



u

u

p



p

to

a



a

a

m



m

maximum of 2 Vol % in oxyge

ge

gen,


n,

 stabilizing the

e

e

 ani



i

ma

ma



ma

l

ls at a breathing rate of 



ap

pp

r



pr

ox

o



imately 

y

70



70

7

b



b

bre


re

a

at



a

hs

hs



hs

p

p



p

er

er



er m

m

min



in

n

ut



ut

ut

e



e. 

Th

Th



e

e

e



MR

MR

M



I

 



pr

pr

rot



ot

oc

o



oc

o

ol



ol

s

s co



o

o

ns



ns

sis


is

is

te



te

te

d



d

d o


of

f

t



t

thr


hr

hr

e



ee

ee

p



p

par


ar

a

t



ts

ts



Fi

Fi

r



rs

r

t,



t

t,

a



a

a

r



ret

et

tro



ro

r

s



sp

sp

ec



ec

ec

ti



ti

v

v



ve

ly

ly



ly g

g

g



at

at

a ed



ed

e

m



m

mu

u



ulti

i

 s



li

li

ice



ce

 

ntragate-Flas



as

s



h

h

pi



pi

p

lo



lo

lo

t



t

sc



sc

c

an



a

a

w



w

w

as



as

as

p



p

p

er



er

er

fo



fo

o

rm



rm

rm

ed



ed

e

i



i

i



n

or



or

or

de



de

d



r

r

to



to

to

v



v

er

er



r

if

if



if



y

th

th



th



e

an

an



an

im

m



m

al

al



al

p

p



p

os

os



os

it

it



it

io

io



i



n

an

an



an



d

to

to



o

 place the 

 by guest on December 22, 2017

http://circ.ahajournals.org/

Downloaded from 


DOI: 10.1161/CIRCULATIONAHA.113.008157 

T



1

 contrast while maintaining sufficient signal to noise was employed. In order to obtain images 

from the late diastolic phase, the trigger delay was chosen deducting TR and an additional 20ms 

from the ECG gating derived period time. Blood signal attenuation was achieved through a 7mm 

saturation slice placed parallel to the imaging slices across the atrium. Images were acquired 

once pre contrast agent application, and minimum 5 scans lasting ~50 minutes after injection of 

LIBS-MPIO/control-MPIO, in order to monitor platelet invasion. Subsequently, injection of 

MultiHance™ and further 4-5 scans followed for monitoring late enhancement through 

gadolinium uptake. With four averages the sequence parameters included a TE/TR of 

2.8ms/35ms, a flip angle of 50°, a bandwidth of 81.5kHz, a slice thickness of 0.6mm, a Field of 

View of 25x25mm, and a matrix size of 256x256 resulting in a resolution of 100μm in plane. To 

achieve the best signal to noise ratio, we refrained from obtaining cine-like movies with the 

necessity of repeated excitation pulses, but focused on the recording of late diastolic single 

frames. 


Download 1.2 Mb.

Do'stlaringiz bilan baham:
1   2   3   4   5   6   7




Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling